Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9+ cancer stem cells in ulcerative colitis-related cancer

Ryo Seishima, Koji Okabayashi, Osamu Nagano, Hirotoshi Hasegawa, Masashi Tsuruta, Masayuki Shimoda, Kaori Kameyama, Hideyuki Saya, Yuko Kitagawa

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint Dive into the research topics of 'Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9<sup>+</sup> cancer stem cells in ulcerative colitis-related cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences